Clinical Considerations in Premenopausal Osteoporosis

Archives of Internal Medicine

Volumn 164, Issue 6, 2004, Pages 603-614

  Gourlay, Margaret L ^a,b   Brown, Sue A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ESTROGEN; GESTAGEN; GLUCOCORTICOID; GONADORELIN AGONIST; HORMONE; PROTEIN; RALOXIFENE; THYROID EXTRACT;

AMENORRHEA; ANOREXIA NERVOSA; BODY WEIGHT; BONE DENSITY; BONE GROWTH; BONE MASS; BONE MINERAL; CALCIUM INTAKE; CALCIUM METABOLISM; CORTICOSTEROID INDUCED OSTEOPOROSIS; DIET; DIET THERAPY; DISEASE ASSOCIATION; EATING DISORDER; ETHNIC DIFFERENCE; FEMALE; HEREDITY; HUMAN; NUTRITION; OLIGOMENORRHEA; OSTEOLYSIS; OSTEOPOROSIS; OUTCOMES RESEARCH; PHYSICAL ACTIVITY; PREMENOPAUSAL OSTEOPOROSIS; PREMENOPAUSE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN INTAKE; RACE DIFFERENCE; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SMOKING; STEROID THERAPY; STRESS FRACTURE; VITAMIN D METABOLISM;

ADULT; ANOREXIA NERVOSA; BONE DENSITY; CALCIUM; CONTRACEPTIVES, ORAL; DENSITOMETRY, X-RAY; EXERCISE; FEMALE; GLUCOCORTICOIDS; HUMANS; OSTEOPOROSIS; PREMENOPAUSE; RISK FACTORS; WEIGHT LOSS;

EID: 1642341806     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.6.603     Document Type: Review

References (138)

1. Agency for Healthcare Research and Quality. Osteoporosis in postmenopausal women: diagnosis and monitoring: summary. Available at: http: //www.ahrq.gov/clinic/epcsums/osteosum .htm. Accessed April 10, 2003.
2. Cuddihy M, Gabriel S, Crowson C, Fallon W, Melton LJ III. Forearm fractures as predictors of subsequent osteoporotic fractures. Osteoporos Int. 1999;9:469-475.
3. Honkanen R, Tuppurainen M, Kroger H, Alhava E, Puntila E. Associations of early premenopausal fractures with subsequent fractures vary by sites and mechanisms of fractures. Calcif Tissue Int. 1997;60:327-331.
4. Rothberg AD, Matshidze PK. Perimenopausal wrist fracture: an opportunity for prevention and management of osteoporosis. S Afr Med J. 2000; 90:1121-1124.
5. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785-795.
6. Osteoporosis prevention, diagnosis, and therapy. NIH Consens Statement. 2000;17:1-45.
7. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312:1254-1259.
8. Cummings S, Bates D, Black D. Clinical use of bone densitometry: scientific review. JAMA. 2002;288:1889-1900.
9. World Health Organization Study Group. Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis. Geneva, Switzerland: World Health Organization; 1994. WHO Technical Report Series No. 843.
10. Matkovic V, Jelic T, Wardlaw G, et al. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis: inference from a cross-sectional model. J Clin Invest. 1994;93:799-808.
11. Bonnick S, Nichols D, Sanborn C, et al. Dissimilar spine and femoral Z-scores in premenopausal women. Calcif Tissue Int. 1997;61:263-265.
12. Ryan P. Bone densitometry in the management of Colles' fractures: which site to measure? Br J Radiol. 2001;74:1137-1141.
13. Abrams S, Copeland K, Gunn S, Gundberg C, Oerter Klein K, Ellis K. Calcium absorption, bone mass accumulation, and kinetics increase during early pubertal development in girls. J Clin Endocrinol Metab. 2000;85:1805-1809.
14. Bailey D, Martin A, McKay H, Whiting S, Mirwald R. Calcium accretion in girls and boys during puberty: a longitudinal analysis. J Bone Miner Res. 2000;15:2245-2250.
15. Boot A, Ridder M, Pols H, Krenning E, Muinck Keizer-Schrama S. Bone mineral density in children and adolescents: relation to puberty, calcium intake, and physical activity. J Clin Endocrinol Metab. 1997;82:57-62.
16. Ellis K, Shypailo R, Hardin D, et al. Z score prediction model for assessment of bone mineral content in pediatric diseases. J Bone Miner Res. 2001;16:1658-1664.
17. Bachrach L, Hastie T, Wang M, Balasubramanian N, Marcus R. Bone mineral acquisition in healthy Asian, hispanic, black and caucasian youth: a longitudinal study. J Clin Endocrinol Metab. 1999;84:4702-4712.
18. Heaney R, Abrams S, Dawson-Hughes B, et al. Peak bone mass. Osteoporos Int. 2000;11:985-1009.
19. Soyka L, Fairfield W, Klibanski A. Hormonal determinants and disorders of peak bone mass in children. J Clin Endocrinol Metab. 2000;85:3951-3963.
20. Lofman O, Larsson L, Toss G. Bone mineral density in diagnosis of osteoporosis: reference population, definition of peak bone mass, and measured site determine prevalence. J Clin Densitom. 2000;3:177-186.
21. Tenenhouse A, Joseph L, Kreiger N, et al. Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int. 2000;11:897-904.
22. Bonjour J, Theintz G, Buchs B, Slosman B, Rizzoli R. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab. 1991; 73:555-563.
23. Pocock N, Eisman J, Hoper J, Yeates M, Sambrook P, Eberl S. Genetic determinants of bone mass in adults: a twin study. J Clin Invest. 1987; 80:706-710.
24. Guerguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G. Segregation analysis and variance components analysis of bone mineral density in healthy families, J Bone Miner Res. 1995; 10:2017-2022.
25. Seeman E, Hopper J, Bach L, et al. Reduced bone mass in daughters of women with osteoporosis. N Engl J Med. 1989;320:554-558.
26. Ferrari S, Rizzoli R, Slosman D, Boniour JP. Familial resemblance for bone mineral mass is expressed before puberty. J Clin Endocrinol Metab. 1998;83:358-361.
27. Gilsanz V, Gibbens D, Carlson M, Boechat M, Cann C, Schulz E. Peak trabecular vertebral density: a comparison of adolescent and adult females. Calcif Tissue Int. 1988;43:260-262.
28. Sowers MR, Galuska DA. Epidemiology of bone mass in premenopausal women. Epidemiol Rev. 1993;15:374-398.
29. Bainbridge K, Sowers M, Crutchfield M, Lin X, Jannausch M, Harlow S. Natural history of bone loss over 6 years among premenopausal and early postmenopausal women. Am J Epidemiol. 2002;156:410-417.
30. Hui SL, Perkins AJ, Zhou L, et al. Bone loss at the femoral neck in premenopausal white women: effects of weight change and sex-hormone levels. J Clin Endocrinol Metab. 2002;87:1539-1543.
31. Salamone LM, Glynn NW, Black DM, et al. Determinants of premenopausal bone mineral density: the interplay of genetic and lifestyle factors. J Bone Miner Res. 1996;11:1557-1565.
32. Slemenda C, Longcope C, Peacock M, Hui S, Johnston CC. Sex steroids, bone mass, and bone loss: a prospective study of pre-, peri-, and postmenopausal women. J Clin Invest. 1996;97:14-21.
33. Slemenda C, Hui S, Longcope C, Wellman H, Johnston CC. Predictors of bone mass in perimenopausal women: a prospective study of clinical data using photon absorptiometry. Ann Intern Med. 1990;112:96-101.
34. Cummings S. Risk factors for hip fracture in white women. N Engl J Med. 1995;332:767-774.
35. Nevitt M, Cummings S, the Study of Osteoporotic Fractures Research Group. Type of fall and risk of hip and wrist fractures: the study of osteoporotic fractures. J Am Geriatr Soc. 1993;41: 1226-1234.
36. Dargent-Molina P, Douchin M, Cormier C, Meunier P, Breart G, Group ES. Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: the EPIDOS prospective study. Osteoporos Int. 2002;13:593-599.
37. Moreira-Kulak CA, Schussheim OH, McMahon DJ, et al. Osteoporosis and low bone mass in premenopausal and perimenopausal women. Endocr Pract. 2000;6:296-304.
38. Peris P, Guanabens P, De Osaba M, et al. Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish women. Semin Arthritis Rheum. 2002;32: 64-70.
39. Tudor-Locke C, McColl RS. Factors related to variation in premenopausal bone mineral status: a health promotion approach. Osteoporos Int. 2000;11:1-24.
40. Eccleshall TR, Garnero P, Gross C, Delmas PD, Feldman D. Lack of correlation between start codon polymorphism of the vitamin D receptor gene and bone mineral density in premenopausal French women: the OFELY study. J Bone Miner Res. 1998;13:31-35.
41. Garnero P, Borel O, Sornay-Rendu E, Delmas PD. Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women. J Bone Miner Res. 1995; 10:1283-1288.
42. Barger-Lux MJ, Heaney RP, Hayes J, DeLuca HF, Johnson ML, Gong G. Vitamin D receptor gene polymorphism, bone mass, body size, and vitamin receptor density. Calcif Tissue Int. 1995; 57:161-162.
43. Salamone LM, Ferrell R, Black DM, et al. The association between vitamin D receptor gene polymorphisms and bone mineral density at the spine, hip and whole-body in premenopausal women. Osteoporos Int. 1996;6:63-68.
44. Spotila LD, Caminis J, Johnston R, et al. Vitamin D receptor genotype is not associated with bone mineral density in three ethnic/regional groups. Calcif Tissue Int. 1996;59:235-237.
45. Jarvinen TL, Jarvinen TA, Sievanen H, et al. Vitamin D receptor alleles and bone's response to physical activity. Calcif Tissue Int. 1998;62:413-417.
46. Mizunuma H, Hosoi T, Okano H, et al. Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and post-menopausal women. Bone. 1997;21:379-383.
47. Ho A, Yeung SS, Kung AW. Pvull polymorphisms of the estrogen receptor α and bone mineral density in hearthy southern Chinese women. Calcif Tissue Int. 2000;66:405-408.
48. Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, et al. Estrogen receptor gene polymorphism is associated with bone mineral density in premenopausal women but not in postmenopausal women. J Endocrinol Invest. 1998;21:487-493.
49. Sriussadaporn S, Srimuninnimit V, Ploybutr S, et al. Association between estrogen receptor concentration in breast cancer tissue and bone mineral density. J Med Assoc Thai. 2002;85:327-333.
50. Tokita A, Kelly PJ, Nguyen TV, et al. Genetic influences on type I collagen synthesis and degradation: further evidence for genetic regulation of bone turnover. J Clin Endocrinol Metab. 1994;78:1461-1466.
51. Hampson G, Evans C, Petitt RJ, et al. Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia. 1998;41:1314-1320.
52. Rosen C, Kurland E, Vereault D, et al. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J Clin Endocrinol Metab. 1998;83:2286-2290.
53. Takacs J, Koller D, Peacock M, et al. Sibling pair linkage and associations between bone mineral density and the insulin-like growth factor I gene locus. J Clin Endocrinol Metab. 1999;84:4467-4471.
54. Truscott JG, Simpson DS, Fordham JN. A suggested methodology for the construction of national bone densitometry reference ranges: 1372 Caucasian women from four UK sites. Br J Radiol 1997;70:1245-1251.
55. Kao CH, Chen CC, Wang SJ. Normal data for lumbar spine bone mineral content in healthy elderly Chinese: influences of sex, age, obesity and ethnicity. Nucl Med Commun. 1994;15:916-920.
56. Lehmann R, Wapniarz M, Randerath O, et al. Dual-energy X-ray absorptiometry at the lumbar spine in German men and women: a cross-sectional study. Calcif Tissue Int. 1995;56:350-354.
57. Daniels ED, Pettifor JM, Schnitzler CM, Moodley GP, Zachen D. Differences in mineral homeostasis, volumetric bone mass and femoral neck axis length in black and white South African women. Osteoporos Int. 1997;7:105-112.
58. Harris SS, Wood MJ, Dawson-Hughes B. Bone mineral density of the total body and forearm in premenopausal black and white women. Bone. 1995;16(suppl):311S-315S.
59. Lauderdale D, Jacobsen S, Furner S, Levy P, Brody J, Goldberg J. Hip fracture incidence among elderly Asian-American populations. Am J Epidemiol. 1997;146:502-509.
60. Davies M, Hall M, Jacobs H. Bone mineral loss in young women with amenorrhea. BMJ. 1990; 301:790-793.
61. Warren M, Brooks-Gunn J, Fox R, Holderness C, Hyle E, Hamiltion W. Osteopenia in exercise-associated amenorrhea using ballet dancers as a model: a longitudinal study. J Clin Endocrinol Metab. 2002;87:3162-3168.
62. Micklesfield LK, Lambert EV, Fataar AB, Noakes TD, Myburgh KH. Bone mineral density in mature, premenopausal ultramarathon runners. Med Sci Sports Exerc. 1995;27:688-696.
63. Lindsay P, Tohme J, Kanders B. The effect of oral contraceptive use on vertebral bone mass in pre- and post-menopausal women. Contraception. 1986;34:333-340.
64. Recker R, Davies K, Hinders S, Heaney R, Stegman M, Kimmel D. Bone gain in young adult women. JAMA. 1992;268:2403-2408.
65. Prior JC, Kirkland SA, Joseph L, et al. Oral contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study. CMAJ. 2001;165:1023-1029.
66. Polatti F, Perotti F, Filippa N, Gallina D, Nappi R. Bone mass and long-term monophasic oral contraceptive treatment in young women. Contraception. 1995;51:221-224.
67. Naessen T, Olsson SE, Gudmundson J. Differential effects on bone density of progestogenonly methods for contraception in premenopausal women. Contraception. 1995;52:35-39.
68. Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid I. Bone density in women receiving depot medroxyprogesterone acetate for contraception. BMJ. 1991;303:13-16.
69. Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM. Injectable hormone contraception and bone density: results from a prospective study. Epidemiology. 2002;13:581-587.
70. Sorenson M, Collins P, Ong P, et al. Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance. Circulation. 2002;106:1646-1651.
71. Clark M, Sowers M, Levy B, Tenhundfeld P. Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception. Fertil Steril. 2001;75:871-877.
72. Ramsdale SJ, Bassey EJ, Pye DJ. Dietary calcium intake relates to bone mineral density in premenopausal women. Br J Nutr. 1994;71:77-84.
73. Teegarden D, Lyle RM, McCabe GP, et al. Dietary calcium, protein, and phosphorus are related to bone mineral density and content in young women. Am J Clin Nutr. 1998;68:749-754.
74. Citron JT, Ettinger B, Genant HK. Spinal bone mineral loss in estrogen-replete, calcium-replete premenopausal women. Osteoporos Int. 1995;5:228-233.
75. Cooper C, Atkinson EJ, Hensrud DD, et al. Dietary protein intake and bone mass in women. Calcif Tissue Int. 1996;58:320-325.
76. Hyldstrup L, Andersen T, McNair P, Breum L, Transbol I. Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction. Acta Endocrinol (Copenh). 1993;129: 393-398.
77. Fogelholm GM, Sievanen HT, Kukkonen-Harjula TK, Pasanen ME. Bone mineral density during reduction, maintenance and regain of body weight in premenopausal, obese women. Osteoporos Int. 2001;12:199-206.
78. Salamone LM, Cauley JA, Black DM, et al. Effect of a lifestyle intervention on bone mineral density in premenopausal women: a randomized trial. Am J Clin Nutr. 1999;70:97-103.
79. Shapses SA, Von Thun NL, Heymsfield SB, et al. Bone turnover and density in obese premenopausal women during moderate weight loss and calcium supplementation. J Bone Miner Res. 2001;16:1329-1336.
80. Van Loan MD, Keim NL. Influence of cognitive eating restraint on total-body measurements of bone mineral density and bone mineral content in premenopausal women aged 18-45 y: a cross-sectional study. Am J Clin Nutr. 2000;72:837-843.
81. Fogelholm M, Sievänen H, Heinonen A, et al. Association between weight cycling history and bone mineral density in premenopausal women. Osteoporos Int. 1997;7:354-358.
82. Wallace B, Cumming R. Systematic review of randomized trials of the effect of exercise on bone mass in pre- and postmenopausal women. Calcif Tissue Int. 2000;67:10-18.
83. Goto S, Ishima M, Shimizu M, Kobayashi Y, Moriya H. A longitudinal study for femoral neck bone mineral density increases in premenopausal caddies using dual-energy X-ray absorptiometry. J Bone Miner Metab. 2001;19:125-130.
84. Winters KM, Snow CM. Detraining reverses positive effects of exercise on the musculoskeletal system in premenopausal women. J Bone Miner Res. 2000;15:2495-2503.
85. Dornemann TM, McMurray RG, Renner JB, Anderson JJ. Effects of high-intensity resistance exercise on bone mineral density and muscle strength of 40-50-year-old women. J Sports Med Phys Fitness. 1997;37:246-251.
86. Lohman T, Going S, Pamenter R, et al. Effects of resistance training on regional and total bone mineral density in premenopausal women: a randomized prospective study. J Bone Miner Res. 1995;10:1015-1024.
87. Ito M, Nakamura T, Ikeda S, et al. Effects of lifetime volleyball exercise on bone mineral densities in lumbar spine, calcaneus and tibia for pre-, peri- and postmenopausal women. Osteoporos Int. 2001;12:104-111.
88. Zipfel S, Seibel M, Lowe B, Beumont P, Kasperk C, Herzog W. Osteoporosis in eating disorders: a follow-up study of patients with anorexia and bulimia nervosa. J Clin Endocrinol Metab. 2001; 86:5227-5233.
89. Grinspoon S, Thomas E, Pitts S, et al. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med. 2000;133:790-794.
90. Biller B, Saxe V, Herzog D, Rosenthal D, Holzman S, Klibanski A. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab. 1989;68:548-554.
91. Espallargues M, Sampietro-Colom L, Estrada M, et al. Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literature. Osteoporos Int. 2001;12:811-822.
92. Vartej P, Polana C, Vartej I. Effects of hyperprolactinemia on osteoporotic fracture risk in premenopausal women. Gynecol Endocrinol. 2001; 15:43-47.
93. Redlich K, Ziegler S, Kiener HP, et al. Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus. Ann Rheum Dis. 2000;59: 308-310.
94. Aris R, Renner J, Winders A, et al. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Intern Med. 1998;128:186-193.
95. Honkanen R, Kroger H, Alhava E, Turpeinen P, Tuppurainen M, Saarikoski S. Lactose intolerance associated with fractures of weight-bearing bones in Finnish women aged 38-57 years. Bone. 1997;21:473-477.
96. Harlow B, Wise L, Otto M, Soares C, Cohen L. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause. Arch Gen Psychiatry. 2003;60:29-36.
97. NIH/National Library of Medicine. The P.O.W.E.R. Study: bone loss in premenopausal women with depression. Sponsored by the National Institute of Mental Health. Available at: http:/www .clinicaltrials.gov. Accessed April 10, 2003.
98. van Staa T, Leufkens G, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int. 2002;13:777-787.
99. Fujita K, Kasayama S, Hashimoto J, et al. Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women. J Bone Miner Res. 2001;16:782-787.
100. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med. 2001;345:941-947.
101. American College of Rheumatology. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum. 2001;44:1496-1503.
102. Yood R, Harrold L, Fish L, et al. Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting. Arch Intern Med. 2001;161:1322-1327.
103. Schneider D, Barrett-Connor E, Morton O. Thyroid hormone use and bone mineral density in elderly women: effects of estrogen. JAMA. 1994; 271:1245-1249.
104. Bauer O, Browner WS, Cauley JA, et al. Factors associated with appendicular bone mass in older women. Ann Intern Med. 1993;118:657-665.
105. Caraballo P, Gabriel S, Castro M, Atkinson EJ, Melton LJ III. Changes in bone density after exposure to oral anticoagulants: a meta-analysis. Osteoporos Int. 1999;9:441-448.
106. Ward KD, Kiesges RC. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int. 2001;68:259-270.
107. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ. 1997;315:841-846.
108. Rapuri P, Gallagher J, Balhorn K, Ryschon K. Smoking and bone metabolism in elderly women. Bone. 2000;27:429-436.
109. Brot C, Jorgensen N, Sorensen O. The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr. 1999;53:920-926.
110. Cummings S, Melton LJ III. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002; 359:1761-1767.
111. Korpelainen R, Orava S, Karpakka J, Siira P, Hulkko A. Risk factors for recurrent stress fractures in athletes. Am J Sports Med. 2001;29: 304-310.
112. Lauder T, Dixit S, Pezzin L, Williams M, Campbell C, Davis G. The relation between stress fractures and bone mineral density: evidence from active-duty army women. Arch Phys Med Rehabil. 2000;81:73-79.
113. Valentino R, Savastano S, Tommaselli A, D'Amore G, Dorato M, Lombardi G. The influence of intense ballet training on trabecular bone mass, hormone status, and gonadotropin structure in young women. J Clin Endocrinol Metab. 2001; 86:4674-4678.
114. Warren M, Brooks-Gunn J, Hamilton L, Warren L, Hamilton W. Scoliosis and fractures in young ballet dancers: relation to delayed menarche and secondary amenorrhea. N Engl J Med. 1986; 314:1348-1353.
115. LaBan M, Wilkins J, Sackeyfio A, Taylor R. Osteoporotic stress fractures in anorexia nervosa: etiology, diagnosis and review of four cases. Arch Phys Med Rehabil. 1995;76:884-887.
116. Maugars Y, Berthelot J, Lalande S, Charlier C, Prost A. Osteoporotic fractures revealing anorexia nervosa in five females. Rev Rhum Engl Ed. 1996;63:201-206.
117. , Lucas A, Melton LJ III, Crowson C, O'Fallon WM. Long-term fracture risk among women with anorexia nervosa: a population-based cohort study. Mayo Clin Proc. 1999;74:972-977.
118. Cheng J, Guo X, Sher A. Persistent osteopenia in adolescent idiopathic scoliosis: a longitudinal follow-up study. Spine. 1999;24:1218-1222.
119. Smith F, Latchford G, Hall R, Millner P, Dickson R. Indications of disordered eating behavior in adolescent patients with idiopathic scoliosis. J Bone Joint Surg Br. 2002;84:392-394.
120. Nussinovitch M, Finkelstein Y, Amir J, Greenbaum E, Volovitz B. Adolescent screening for orthopedic problems in high school. Public Health. 2002;116:30-32.
121. Soucacos P, Zacharis K, Soultanis K, Gelalis J, Xenakis T, Beris A. Risk factors for idiopathic scoliosis: review of a 6-year prospective study. Orthopedics. 2000;23:833-838.
122. Hosmer WD, Genant HK, Browner WS. Fractures before menopause: a red flag for physicians. Osteoporos Int. 2002;13:337-341.
123. Wu F, Mason B, Horne A, et al. Fractures between the ages of 20 and 50 years increase women's risk of subsequent fractures. Arch Intern Med. 2002;162:33-36.
124. Goulding A, Gold E, Walker R, Lewis-Barned N, Women with past history of bone fracture have low spinal bone density before menopause. NZ Med J. 1997;110:232-233.
125. Torgerson DJ, Campbell MK, Thomas RE, Reid DM. Prediction of perimenopausal fractures by bone mineral density and other risk factors. J Bone Miner Res. 1996;11:293-297.
126. Homik J, Cranney A, Shea B, et al. Bisphosphonates for steroid-induced osteoporosis [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 2002; issue 4.
127. Klibanski A, Biller B, Schoenfeld D, Herzog D, Saxe V. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab. 1995; 80:898-904.
128. Golden N, Lanzkowsky L, Schebendach J, Palestro C, Jacobson M, Shenker I. The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa. J Pediatr Adolesc Gynecol. 2002;15:135-143.
129. Palomba S, Orio F Jr, Morelli M, et al. Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism. J Clin Endocrinol Metab. 2002;87:4476-4481.
130. Minsker D, Manson J, Peter C. Effects of the bisphosphonate, alendronate, on parturition in the rat. Toxicol Appl Pharmacol. 1993;121:217-223.
131. Patlas N, Golomb G, Yaffe P, Pinto T, Breuer E, Ornoy A. Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology. 1999;60:68-73.
132. Black DM, Cummings SR, Karpf DB, for the Fracture Intervention Trial Research Group. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet. 1996;348:1535-1541.
133. Harris S, Watts N, Genant H, et al. Effects of rised-ronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. JAMA. 1999;282:1344-1352.
134. US Preventive Services Task Force. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med. 2002;137:526-528.
135. National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. Available at: http://www.nof.org. Accessed April 10, 2003.
136. Brigham and Women's Hospital. Osteoporosis: Guide to Prevention, Diagnosis, and Treatment. Boston, Mass: Brigham and Women's Hospital; 1999.
137. American College of Radiology. ACR Appropriateness Criteria for Osteoporosis and Bone Mineral Density. Reston, Va: American College of Radiology; 1998 (revised 2001).
138. American Academy of Orthopaedic Surgeons/American College of Obstetricians and Gynecologists/American Geriatrics Society/American College of Radiology/American College of Rheumatology/American Academy of Physical Medicine and Rehabilitation/American Association of Clinical Endocrinologists/National Osteoporosis Foundation/Endocrine Society/American Society for Bone and Mineral Research. Physician's Guide to Prevention and Treatment of Osteoporosis. Belle Mead, NJ: Excerpta Medica Inc; 1999.